BIOTECanada
- Website
- biotech.ca · all feeds from this site
- Feed URL
http://www.biotech.ca/feed/
Read it in your FeedListing reader
Or add to: Feedly Inoreader Raw feed
Latest posts
-
Specific Biologics – Announces Oversubscribed US$35 Million Series A Financing to Advance Gene-Editing Therapy for ALS
TORONTO, Nov. 2, 2026 /CNW/ — Specific Biologics, a biotechnology company pioneering a new generation of precision gene-editing therapies for serious genetic diseases, today announced the closing of an oversubscribed Read More
-
BIOTECanada Welcomes Recognition of Biotechnology as a Strategic Canadian Capability
BIOTECanada welcomes the federal government’s recognition of biotechnology and pharmaceuticals as strategic capabilities in Canada’s new National Security Strategy. This is an important step in recognizing the role biotechnology plays Read More
-
BIOTECanada Strengthens Canada–Korea Biotechnology Collaboration at BIX 2026
BIOTECanada was pleased to be a part of the Canadian delegation attending BIX 2026 in Seoul, where Canada was named the official Country of Honour. During the visit, BIOTECanada President Read More
-
Korea’s Leading Biotech and Pharmaceutical Convention BIX 2026 Opens in Seoul with 300+ Companies and 600 Booths
by Sung, Jae Jun BIOPLUS-INTERPHEX KOREA 2026 (BIX 2026), a leading biotechnology and pharmaceutical convention, opened at COEX in Seoul on October 28. Hosted by Korea Biotechnology Industry Organization (KoreaBIO), Read More
-
BIOTECanada Statement: Federal Government Moves Forward on Venture and Growth Capital
BIOTECanada welcomes the federal government’s latest steps to strengthen Canada’s venture and growth capital market, including moving forward with the Venture and Growth Capital Catalyst Initiative (Growth VCCI) and outlining Read More
-
BIOTECanada Consultation on a proposed interim approach to speed up the review of certain pediatric drugs
October 23, 2026 Bureau of Policy, Science and International ProgramsPharmaceutical Drugs DirectorateHealth Products and Food BranchHealth Canada Email: policy_bureau_enquiries@hc-sc.gc.ca Re. Comments on Consultation on a proposed interim approach to speed Read More
-
BIOTECanada welcomes the federal government’s new Cabinet Directive on Regulatory Competitiveness and Red Tape Reduction
Regulatory modernization has been a consistent focus of BIOTECanada’s advocacy,including in our federal budget recommendations. The directive’s emphasis on reducingunnecessary burden and improving regulatory alignment is consistent with our call Read More
-
Important progress for Canada’s rare disease community
BIOTECanada welcomes the federal government’s commitment to ongoing $500 million annual funding for the National Strategy for Drugs for Rare Diseases and to continued collaboration with provincial and territorial partners. Read More
-
Canada’s life sciences strength is capturing global attention
Read the article below: Bio-Europe Autumn Supplement 2026: Featured on Pages 26-27
-
MFI – releases Canopy, a chemistry-first decision intelligence platform for small-molecule discovery
Its first module, Willow, combines CYP metabolism modelling with real-time molecular property calculations in software designed for medicinal chemists. Montreal, Quebec, October 13, 2026 – Molecular Forecaster Inc. (MFI) today Read More
-
Health Canada’s Ministerial Reliance Order Guidance on Foreign Regulatory Authorities as part of Canada Gazette Part II
BIOTECanada provided feedback to Health Canada on a Draft Guidance on the Ministerial Reliance Order concerning decisions or documents on certain drugs by foreign regulatory authorities as part of Canada Read More
-
Accelerating Access to Cancer Medicines: Early Learnings from Ontario’s FAST Pilot
The National Joint Oncology Project Team, a collaboration between BIOTECanada and Innovative Medicines Canada (IMC), identifies practical policy solutions that can help Canadians access breakthrough oncology therapies more quickly. As Read More